ウイルスベクター・プラスミドDNA製造市場：細胞株、タイプ、トランスフェクション、適応症、ワークフロー、用途、エンドユーザー別-2023-2030年の世界予測

ウイルスベクター・プラスミドDNA製造の世界市場は大きく成長すると予測され、2023年にはCAGR 25.30%で15億648万米ドルが予測され、2030年には驚異的な73億2,262万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のウイルスベクター・プラスミドDNA製造市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ウイルスベクター・プラスミドDNA製造の世界市場規模および予測は？

2.予測期間中、世界のウイルスベクター・プラスミドDNA製造市場を形成するCOVID-19の阻害要因と影響は？

3.ウイルスベクター・プラスミドDNA製造の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ウイルスベクター・プラスミドDNA製造の世界市場における競争戦略は？

5.ウイルスベクター・プラスミドDNA製造の世界市場における技術動向と規制の枠組みは？

6.ウイルスベクター・プラスミドDNA製造の世界市場における主要ベンダーの市場シェアは？

7.ウイルスベクター・プラスミドDNA製造の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんなどのいくつかの治療でウイルスベクターの使用が増加しているため、プラスミドとベクターの開発が求められています
    • 遺伝子治療の利点についての認識
    • 研究開発活動への資金の増加
  • 抑制要因
    • 訓練を受けた専門家が限られており、製造プロセスが複雑である
  • 機会
    • 合成遺伝子に対する新たな需要
    • FDAおよびその他の統治機関からの遺伝子治療製品の承認
  • 課題
    • 倫理的懸念、物流上の問題、および関連コスト
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ウイルスベクター・プラスミドDNA製造市場細胞株別

• 試験管内で
• 生体内

第7章 ウイルスベクター・プラスミドDNA製造市場：タイプ別

• アデノ随伴ウイルス
• アデノウイルス
• レンチウイルス
• プラスミドDNA

第8章 ウイルスベクター・プラスミドDNA製造市場トランスフェクション別

• 安定したトランスフェクション
• 一過性トランスフェクション

第9章 ウイルスベクター・プラスミドDNA製造市場適応症別

• がん
• 遺伝性疾患
• 感染症

第10章 ウイルスベクター・プラスミドDNA製造市場：ワークフロー別

• 下流処理
  • フィルフィニッシュ
  • 精製
• 上流処理
  • ベクトルの増幅と拡張
  • ベクターの回収/収集

第11章 ウイルスベクター・プラスミドDNA製造市場：用途別

• アンチセンスとRNAi
• 細胞治療
• 遺伝子治療
• ワクチン学

第12章 ウイルスベクター・プラスミドDNA製造市場：エンドユーザー別

• バイオテクノロジー企業
• 調査機関

第13章 南北アメリカのウイルスベクター・プラスミドDNA製造市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域のウイルスベクター・プラスミドDNA製造市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカのウイルスベクター・プラスミドDNA製造市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第17章 掲載企業一覧

第18章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2022 VS 2030
• FIGURE 3. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2022 VS 2030 (%)
• FIGURE 5. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2022 VS 2030 (%)
• FIGURE 7. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 8. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
• FIGURE 9. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 10. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 11. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 12. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET DYNAMICS
• FIGURE 13. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 24. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 25. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 5. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 13. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 16. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 20. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 21. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 25. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 69. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 70. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 71. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 107. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 112. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 114. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 116. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 117. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 118. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 121. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 123. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 125. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 126. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 127. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 139. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 188. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 189. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 190. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 196. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 197. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 198. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 199. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 204. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 205. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 206. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 207. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 208. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 221. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 223. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 225. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 226. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 227. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 230. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 232. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 233. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 234. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 235. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 236. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 239. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 241. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 242. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 243. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 244. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 245. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 248. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 249. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 250. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 251. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 252. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 253. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 254. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 256. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 257. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 258. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 259. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 260. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 261. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 262. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 263. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 265. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 266. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 268. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 269. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 270. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 271. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 272. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 275. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 276. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 277. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 278. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 279. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 280. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
• TABLE 281. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2030 (USD MILLION)
• TABLE 284. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 285. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2030 (USD MILLION)
• TABLE 286. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 287. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 288. NETHERLANDS VIRAL

The Global Viral Vector & Plasmid DNA Manufacturing Market is forecasted to grow significantly, with a projected USD 1,506.48 million in 2023 at a CAGR of 25.30% and expected to reach a staggering USD 7,322.62 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Viral Vector & Plasmid DNA Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Viral Vector & Plasmid DNA Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Cell Line, market is studied across In-vitro and In-Vivo. The In-vitro commanded largest market share of 88.92% in 2022, followed by In-Vivo.

Based on Type, market is studied across Adeno-Associated Virus, Adenovirus, Lentivirus, and Plasmid DNA. The Lentivirus commanded largest market share of 34.21% in 2022, followed by Adeno-Associated Virus.

Based on Transfection, market is studied across Stable Transfection and Transient Transfection. The Stable Transfection commanded largest market share of 60.06% in 2022, followed by Transient Transfection.

Based on Indication, market is studied across Cancer, Genetic Disorder, and Infectious Disease. The Cancer commanded largest market share of 38.62% in 2022, followed by Infectious Disease.

Based on Workflow, market is studied across Downstream Processing and Upstream Processing. The Downstream Processing is further studied across Fill-finish and Purification. The Upstream Processing is further studied across Vector Amplification & Expansion and Vector Recovery/Harvesting. The Downstream Processing commanded largest market share of 55.34% in 2022, followed by Upstream Processing.

Based on Application, market is studied across Antisense & RNAi, Cell Therapy, Gene Therapy, and Vaccinology. The Cell Therapy commanded largest market share of 34.74% in 2022, followed by Gene Therapy.

Based on End User, market is studied across Biotech Companies and Research Institutes. The Biotech Companies commanded largest market share of 81.22% in 2022, followed by Research Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 40.00% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Viral Vector & Plasmid DNA Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Viral Vector & Plasmid DNA Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viral Vector & Plasmid DNA Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viral Vector & Plasmid DNA Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Viral Vector & Plasmid DNA Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Viral Vector & Plasmid DNA Manufacturing Market?

6. What is the market share of the leading vendors in the Global Viral Vector & Plasmid DNA Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Viral Vector & Plasmid DNA Manufacturing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Viral Vector & Plasmid DNA Manufacturing Market, by Cell Line, 2022 vs 2030
• 4.3. Viral Vector & Plasmid DNA Manufacturing Market, by Type, 2022 vs 2030
• 4.4. Viral Vector & Plasmid DNA Manufacturing Market, by Transfection, 2022 vs 2030
• 4.5. Viral Vector & Plasmid DNA Manufacturing Market, by Indication, 2022 vs 2030
• 4.6. Viral Vector & Plasmid DNA Manufacturing Market, by Workflow, 2022 vs 2030
• 4.7. Viral Vector & Plasmid DNA Manufacturing Market, by Application, 2022 vs 2030
• 4.8. Viral Vector & Plasmid DNA Manufacturing Market, by End User, 2022 vs 2030
• 4.9. Viral Vector & Plasmid DNA Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising use of viral vectors in several treatments such as cancer demands developments in plasmids and vectors
    • 5.1.1.2. Awareness on the benefits of gene therapy
    • 5.1.1.3. Increase in funding for research and development activities
  • 5.1.2. Restraints
    • 5.1.2.1. Limited trained professionals and the complexity of the manufacturing process
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging demand for synthetic genes
    • 5.1.3.2. Approval of gene therapy products from the FDA and other governing bodies
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concern, logistical issues, and associated cost
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Viral Vector & Plasmid DNA Manufacturing Market, by Cell Line

• 6.1. Introduction
• 6.2. In-vitro
• 6.3. In-Vivo

7. Viral Vector & Plasmid DNA Manufacturing Market, by Type

• 7.1. Introduction
• 7.2. Adeno-Associated Virus
• 7.3. Adenovirus
• 7.4. Lentivirus
• 7.5. Plasmid DNA

8. Viral Vector & Plasmid DNA Manufacturing Market, by Transfection

• 8.1. Introduction
• 8.2. Stable Transfection
• 8.3. Transient Transfection

9. Viral Vector & Plasmid DNA Manufacturing Market, by Indication

• 9.1. Introduction
• 9.2. Cancer
• 9.3. Genetic Disorder
• 9.4. Infectious Disease

10. Viral Vector & Plasmid DNA Manufacturing Market, by Workflow

• 10.1. Introduction
• 10.2. Downstream Processing
  • 10.2.1. Fill-finish
  • 10.2.2. Purification
• 10.3. Upstream Processing
  • 10.3.1. Vector Amplification & Expansion
  • 10.3.2. Vector Recovery/Harvesting

11. Viral Vector & Plasmid DNA Manufacturing Market, by Application

• 11.1. Introduction
• 11.2. Antisense & RNAi
• 11.3. Cell Therapy
• 11.4. Gene Therapy
• 11.5. Vaccinology

12. Viral Vector & Plasmid DNA Manufacturing Market, by End User

• 12.1. Introduction
• 12.2. Biotech Companies
• 12.3. Research Institutes

13. Americas Viral Vector & Plasmid DNA Manufacturing Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Viral Vector & Plasmid DNA Manufacturing Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. FPNV Positioning Matrix
• 16.2. Market Share Analysis, By Key Player
• 16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

• 18.1. Discussion Guide
• 18.2. License & Pricing